<DOC>
	<DOCNO>NCT01263548</DOCNO>
	<brief_summary>ADHD adult population associate several measure harmful dysfunction . For example , adult ADHD associate high rate separation/divorce never-married status , low educational attainment occupational achievement , absenteeism , presenteeism , job termination , well decrease social function . Individuals adult ADHD likely control comorbid diagnosis bipolar disorder , alcohol substance abuse , well antisocial personality disorder . Psychostimulants frequently employ medication treatment adult ADHD . Several psychostimulants Health Canada US FDA-approved treatment ADHD symptom adulthood . Hitherto , trial evaluate safety efficacy psychostimulant treatment ADHD symptomatology adult individual bipolar disorder . Vyvanse first prodrug stimulant indicate treatment adult ( pediatric ) ADHD . Vyvanse therapeutically inactive molecule ( i.e . prodrug ) . After oral ingestion , lisdexamfetamine convert l-lysine , naturally occur essential amino acid , active d-amphetamine , responsible drug 's activity . Vyvanse provide long duration effect consistent throughout day reduce potential risk abuse . Vyvanse generally well tolerated adverse event profile similar psychostimulant medication . Available evidence indicates treat subject , Vyvanse weight-neutral and/or associate weight loss . Moreover , individual , associate improvement glucose lipid homeostasis . The evaluation safety/tolerability profile well effectiveness lisdexamfetamine `` real-world '' population significant translational value .</brief_summary>
	<brief_title>To Evaluate Safety Metabolic Profile Vyvanse Treatment ADHD Euthymic Adults With Bipolar I/II Disorder</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Bipolar Disorder</mesh_term>
	<mesh_term>Attention Deficit Disorder Hyperactivity</mesh_term>
	<mesh_term>Lisdexamfetamine Dimesylate</mesh_term>
	<criteria>Outpatient status Male female subject age 18 55 year , inclusive Primary diagnosis Bipolar Disorder ADHD accord criterion Diagnostic Statistical Manual Mental Disorders ( DSMIVTR ) use Mini International Neuropsychiatric Interview . Agree use reliable method birth control YMRS score &lt; /= 12 CGIBP &lt; 6 Able willing provide write informed consent Current Axis I primary psychiatric diagnosis Bipolar Disorder ADHD Current Axis II psychiatric disorder primary clinical focus Active alcohol well illicit substance abuse past 3 month Current clinically unstable medical condition . Inability understand engage process inform consent . Inability cooperate study procedure . Presence known allergy hypersensitivity lisdexamfetamine History destabilization expose psychostimulant medication Current high risk suicide Current treatment corticosteroid Electroconvulsive therapy last 1 year Current participation separate clinical research study involve investigational drug</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>May 2012</verification_date>
</DOC>